# ADGM (Adagio Medical Holdings, Inc.) - SEC EDGAR Financial Statements

> Adagio Medical Holdings, Inc. reported $0 in revenue and net income of $822K for the trailing twelve months ended September 30, 2026.

- Canonical: https://convexityos.com/fundamentals/ADGM
- Markdown: https://convexityos.com/fundamentals/ADGM.md
- SEC CIK: 0002006986
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:12 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002006986&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | Sep 30, 2026 |
| Operating Income | TTM | -$18.47M | Operating profit |
| Net Income | TTM | $822K | GAAP bottom line |
| Diluted EPS | TTM | $0.99 | Split-adjusted |
| Free Cash Flow | TTM | -$17.65M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $3.10M | Total debt: $3.12M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2023 |
| --- | --- | --- |
| **Revenue** | $0 | $300K |
| Cost of Revenue | $684K | $1.31M |
| **Gross Profit** | -$684K | -$1.01M |
| Research & Development | $10.64M | $15.40M |
| Selling, General & Admin | $10.57M | $11.54M |
| **Operating Income** | -$21.89M | -$27.94M |
| **EBITDA** | -$20.92M | -$27.41M |
| Interest Income | $477K | $3.0K |
| Interest Expense | $2.91M | $1.66M |
| Income Before Tax | -$25.32M | -$36.59M |
| Income Tax Expense | $0 | $0 |
| **Net Income** | -$25.08M | -$36.59M |
| Basic EPS | -$45.35 | -$1,446.25 |
| **Diluted EPS** | -$45.35 | -$1,446.25 |
| Basic Shares Outstanding | 552.0K | 25.3K |
| Diluted Shares Outstanding | 552.0K | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $137K |
| Cost of Revenue | -- | -- | -- | $58K | $31K | $342K | $253K | $1.52M |
| **Gross Profit** | -- | -- | -- | -$58K | -$31K | -$342K | -$253K | -$1.39M |
| Research & Development | $1.80M | $2.45M | $2.74M | $2.23M | $2.77M | $1.97M | $3.66M | $3.42M |
| Selling, General & Admin | $2.57M | $2.48M | $2.46M | $1.68M | $2.92M | $2.40M | $3.48M | $4.05M |
| **Operating Income** | -$4.37M | -$4.93M | -$5.20M | -$3.97M | -$5.72M | -$4.72M | -$7.40M | -$58.05M |
| **EBITDA** | -$4.18M | -$4.73M | -$4.99M | -$3.73M | -$5.53M | -$4.45M | -$7.13M | -$57.63M |
| Interest Income | $40K | $72K | $107K | $132K | $79K | $102K | $164K | $254K |
| Interest Expense | $843K | $805K | $778K | $775K | $749K | $720K | $662K | $670K |
| **Net Income** | $17.84M | -$6.72M | -$7.00M | -$3.31M | -$10.12M | -$3.95M | -$7.71M | -$57.41M |
| Basic EPS | $2.40 | -$9.01 | -$9.31 | -- | -$19.73 | -$7.81 | -$15.02 | -- |
| **Diluted EPS** | -$5.13 | -$9.01 | -$9.31 | -- | -$19.73 | -$10.51 | -$15.32 | -- |
| Basic Shares Outstanding | 747.7K | 739.6K | 739.6K | -- | 512.7K | 512.2K | 512.0K | -- |
| Diluted Shares Outstanding | 833.3K | 739.6K | 739.6K | -- | 512.7K | 512.2K | 512.0K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $17.11M | $20.59M | $1.38M |
| **Cash & Short-Term Investments** | $17.11M | $20.59M | $1.38M |
| Accounts Receivable, Net | -- | $35K | $71K |
| Inventory | $1.67M | $2.57M | $3.32M |
| Other Current Assets | $316K | $222K | $177K |
| **Total Current Assets** | $20.08M | $25.35M | $5.18M |
| Property, Plant & Equipment, Net | $1.53M | $1.96M | $1.49M |
| Goodwill | $13.97M | $13.97M | $0 |
| Intangible Assets | $6.97M | $6.97M | $0 |
| Other Non-Current Assets | $3.0K | $14K | $23K |
| **Total Non-Current Assets** | $23.17M | $23.10M | $1.64M |
| **Total Assets** | $43.25M | $48.45M | $6.83M |
| Accounts Payable | $1.08M | $2.84M | $3.83M |
| **Total Current Liabilities** | $8.23M | $7.76M | $47.18M |
| Long-Term Debt | $21.04M | $17.18M | $38.27M |
| Other Non-Current Liabilities | -- | $3.62M | $8.0K |
| **Total Non-Current Liabilities** | $22.62M | $20.77M | $203K |
| **Total Liabilities** | $30.85M | $28.54M | $47.38M |
| **Total Debt (incl. Leases)** | $21.76M | $17.37M | $38.40M |
| Common Stock | $2.0K | $2.0K | $1.0K |
| Retained Earnings | -$95.61M | -$70.59M | -$133.6M |
| Accumulated Other Comp. Income | -$99K | $1.0K | $17K |
| **Total Stockholders' Equity** | $12.40M | $19.91M | -$132.0M |
| Total Equity | $12.40M | $19.91M | -$132.0M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.10M | $7.74M | $12.91M | $17.11M | $4.67M | $8.20M | $12.96M | $20.59M |
| **Cash & Short-Term Investments** | $3.10M | $7.74M | $12.91M | $17.11M | $4.67M | $8.20M | $12.96M | $20.59M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | $1.0K | $35K |
| Inventory | $2.72M | $1.99M | $1.60M | $1.67M | $1.55M | $1.84M | $2.31M | $2.57M |
| Other Current Assets | $79K | $43K | $281K | $316K | $811K | $1.08M | $507K | $222K |
| **Total Current Assets** | $6.91M | $10.69M | $15.86M | $20.08M | $8.14M | $12.23M | $17.37M | $25.35M |
| Property, Plant & Equipment, Net | $939K | $1.13M | $1.32M | $1.53M | $1.70M | $1.88M | $2.09M | $1.96M |
| Goodwill | $13.97M | $13.97M | $13.97M | $13.97M | $13.97M | $13.97M | $13.97M | $13.97M |
| Intangible Assets | $6.97M | $6.97M | $6.97M | $6.97M | $6.97M | $6.97M | $6.97M | $6.97M |
| Other Non-Current Assets | -- | -- | $1.0K | $3.0K | $6.0K | $9.0K | $11K | $14K |
| **Total Non-Current Assets** | $22.95M | $23.20M | $23.45M | $23.17M | $23.40M | $23.65M | $23.96M | $23.10M |
| **Total Assets** | $29.86M | $33.88M | $39.31M | $43.25M | $31.55M | $35.88M | $41.34M | $48.45M |
| Accounts Payable | $568K | $699K | $1.22M | $1.08M | $1.02M | $1.31M | $2.65M | $2.84M |
| **Total Current Liabilities** | $7.72M | $7.56M | $8.57M | $8.23M | $9.70M | $4.88M | $6.01M | $7.76M |
| Long-Term Debt | $2.01M | $24.84M | $22.87M | $21.04M | $21.19M | $16.95M | $17.65M | $17.18M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | $3.61M | $3.62M | $3.62M |
| **Total Non-Current Liabilities** | $3.78M | $26.74M | $25.01M | $22.62M | $23.16M | $22.33M | $22.93M | $20.77M |
| **Total Liabilities** | $11.50M | $34.30M | $33.58M | $30.85M | $32.86M | $27.21M | $28.94M | $28.54M |
| **Total Debt (incl. Leases)** | $3.12M | $26.00M | $24.09M | $21.76M | $21.97M | $17.78M | $18.58M | $17.37M |
| Common Stock | -- | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| Retained Earnings | -$91.56M | -$109.4M | -$102.6M | -$95.61M | -$92.30M | -$82.18M | -$78.26M | -$70.59M |
| Accumulated Other Comp. Income | $14K | $10K | -$143K | -$99K | -$95K | -$99K | -$60K | $1.0K |
| **Total Stockholders' Equity** | $18.36M | -$415K | $5.72M | $12.40M | -$1.31M | $8.67M | $12.40M | $19.91M |
| Total Equity | $18.36M | -$415K | $5.72M | $12.40M | -$1.31M | $8.67M | $12.40M | $19.91M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2023 |
| --- | --- | --- |
| Net Income | -$25.08M | -$36.59M |
| Depreciation & Amortization | $970K | $532K |
| Stock-Based Compensation | $1.48M | $442K |
| Change in Receivables | $38K | -$70K |
| Change in Inventory | $931K | -$2.98M |
| Change in Payables | -$1.76M | $2.82M |
| **Operating Cash Flow** | -$19.01M | -$25.65M |
| Capital Expenditure | -$374K | -$333K |
| **Free Cash Flow** | -$19.39M | -$25.98M |
| **Investing Cash Flow** | -$374K | -$340K |
| Common Stock Issued | $16.13M | -- |
| **Financing Cash Flow** | $16.13M | $21.88M |
| **Net Change in Cash** | -$3.48M | -$4.16M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $17.84M | -$6.72M | -$7.00M | -$3.31M | -$10.12M | -$3.95M | -$7.71M | -$57.37M |
| Depreciation & Amortization | $194K | $201K | $210K | $237K | $191K | $271K | $271K | $424K |
| Stock-Based Compensation | $218K | $479K | $389K | $890K | $137K | $234K | $218K | -- |
| Change in Receivables | -- | -- | -$17K | $1.0K | -$2.0K | $5.0K | $34K | $52K |
| Change in Inventory | -$733K | -$382K | $68K | -$122K | $297K | $500K | $256K | $1.53M |
| Change in Payables | -$131K | -$519K | $136K | $58K | -$288K | -$1.33M | -$193K | -$1.58M |
| **Operating Cash Flow** | -$4.61M | -$5.26M | -$4.13M | -$4.14M | -$3.01M | -$4.66M | -$7.21M | -$7.11M |
| Capital Expenditure | -$4.0K | -$6.0K | -$2.0K | $491K | -$520K | -$10K | -$335K | -$702K |
| **Free Cash Flow** | -$4.61M | -$5.27M | -$4.13M | -$3.65M | -$3.53M | -$4.67M | -$7.55M | -$7.81M |
| **Investing Cash Flow** | -$4.0K | -$6.0K | -$2.0K | $491K | -$520K | -$10K | -$335K | -$702K |
| **Net Change in Cash** | -$4.64M | -$5.17M | -$4.20M | $12.43M | -$3.53M | -$4.76M | -$7.62M | -$7.67M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2023 |
| --- | --- | --- |
| **Gross Margin** | -- | -335.3% |
| **Operating Margin** | -- | -9314.0% |
| **Net Profit Margin** | -- | -12196.7% |
| Return on Equity (ROE) | -202.3% | -- |
| Return on Assets (ROA) | -58.0% | -536.1% |
| Current Ratio | 2.44x | 0.11x |
| Quick Ratio | 2.24x | 0.04x |
| Debt to Equity | 1.75x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -1468.6% | -841.3% | -449.1% | -475.8% |
| **Operating Margin** | -- | -- | -- | -- | -55394.2% | -27730.1% | -14634.0% | -14199.3% |
| **Net Profit Margin** | -- | -- | -- | -- | -57798.5% | -24334.6% | -12857.9% | -12304.6% |
| Return on Equity (ROE) | 4.5% | -- | -425.6% | -202.3% | -- | -755.4% | -542.4% | -339.3% |
| Return on Assets (ROA) | 2.8% | -80.1% | -62.0% | -58.0% | -251.0% | -182.5% | -162.7% | -139.4% |
| Current Ratio | 0.90x | 1.41x | 1.85x | 2.44x | 0.84x | 2.50x | 2.89x | 3.27x |
| Quick Ratio | 0.54x | 1.15x | 1.66x | 2.24x | 0.68x | 2.13x | 2.51x | 2.93x |
| Debt to Equity | 0.17x | -- | 4.21x | 1.75x | -- | 2.05x | 1.50x | 0.87x |
| **Revenue Growth (YoY)** | -- | -- | -- | -100.0% | -100.0% | -100.0% | -100.0% | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -380.6% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
